|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 |
| (11) | Patento numeris | 2510001 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10794938.0 |
| Europos patento paraiškos padavimo data | 2010-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-12-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/069120 |
| Data | 2010-12-08 |
| (87) | Numeris | WO 2011/070045 |
| Data | 2011-06-16 |
| (30) | Numeris | Data | Šalis |
| 267446 P | 2009-12-08 | US |
| (72) |
MÜLLER, Bernhard, K., DE
|
| (73) |
AbbVie Deutschland GmbH & Co KG,
Max-Planck-Ring 2a, 65205 Wiesbaden,
DE
|
| (54) | MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION |
| MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION |